Leo Kim is a scientist and biotechnology executive. His background includes research and management in chemistry, biochemistry, bioinformatics, biotechnology, information technology, molecular biology, microbiology, physics, and clinical trial studies. He has been active in new pharmaceutical and biotechnology disease treatment modalities as well as alternative medicine regimes. Leo is a CEO and general partner in a biotechnology venture capital firm where he is tracking the progress of thousands of companies utilizing the latest developments in science.